Report
Valens Research

ADM - Embedded Expectations Analysis - 2019 09 04

Archer-Daniels-Midland Company (ADM:USA) currently trades near historical lows relative to UAFRS-based (Uniform) Assets, with a 0.8x Uniform P/B. At these levels, markets have muted expectations for the firm, and management has concerns about soybean costs, their acquisitions, and slowing demand.

Specifically, management is confident their North American Origination business may have higher soybean input costs, and they may be exaggerating the value they gained from combining their origination and oilseeds business. Furthermore, they may be exaggerating the value of their acquisition of the Ziegler Group, and they may lack confidence in their ability to take advantage of future market opportunities. Additionally, management may be concerned about growing demand for alternative proteins, and they may lack confidence in their ability to improve margins in their European business. Finally, they may be concerned about slowing demand in China, and they appear concerned about the sustainability of recent earnings levels in their Ag Services and Oilseeds segment.
Underlying
Archer-Daniels-Midland Company

Archer Daniels Midland is a human and animal nutrition and an agricultural origination and processing company. The company has three segments: Ag Services and Oilseeds, which includes activities related to the origination, merchandising, transportation, and storage of agricultural raw materials, and the crushing and further processing of oilseeds such as soybeans and soft seeds into vegetable oils and protein meals; Carbohydrate Solutions, which is engaged in corn and wheat wet and dry milling and other activities; and Nutrition, which engages in the manufacturing, sale, and distribution of an array of products including plant-based proteins, natural flavor ingredients, and flavor systems.

Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Valens Research

Other Reports on these Companies
Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch